Ludovic Bigot
Project manager Gustave Roussy
Seminars
Monday 4th May 2026
Comparing & Contrasting Multiple Tumour Models to Dissect Their Translational Relevance
3:45 pm
- Spotlighting the development and application of organoids and PDX models to study adaptive responses to targeted therapies and immunotherapies in prostate cancer
- Demonstrating the translational relevance of patient-derived cell lines, CDX, PDX, PDOs and PDXOs and discussing their pros and cons
- Using clinical data from Phase I and II trials to better understand mechanism of resistance and pathology to develop better therapeutic strategies with a focus on enhancing clinical relevance and predictability power of the models
